Hebei Changshan Valuation

300255 Stock   19.22  0.56  3.00%   
At this time, the firm appears to be overvalued. Hebei Changshan Biochem retains a regular Real Value of USD15.23 per share. The prevalent price of the firm is USD19.22. Our model calculates the value of Hebei Changshan Biochem from evaluating the firm fundamentals such as Return On Asset of -0.12, current valuation of 19.69 B, and Return On Equity of -0.4 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book
9.7113
Enterprise Value
19.7 B
Enterprise Value Ebitda
(33.97)
Price Sales
16.8243
Enterprise Value Revenue
18.668
Overvalued
Today
19.22
Please note that Hebei Changshan's price fluctuation is slightly risky at this time. Calculation of the real value of Hebei Changshan Biochem is based on 3 months time horizon. Increasing Hebei Changshan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hebei Changshan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hebei Stock. However, Hebei Changshan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  19.22 Real  15.23 Hype  20.16
The real value of Hebei Stock, also known as its intrinsic value, is the underlying worth of Hebei Changshan Biochem Company, which is reflected in its stock price. It is based on Hebei Changshan's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hebei Changshan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
15.23
Real Value
22.19
Upside
Estimating the potential upside or downside of Hebei Changshan Biochem helps investors to forecast how Hebei stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hebei Changshan more accurately as focusing exclusively on Hebei Changshan's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.050.050.05
Details
Hype
Prediction
LowEstimatedHigh
13.2020.1627.12
Details

Hebei Changshan Cash

219.38 Million

Hebei Changshan Total Value Analysis

Hebei Changshan Biochem is presently forecasted to have takeover price of 19.69 B with market capitalization of 17.75 B, debt of 927.05 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hebei Changshan fundamentals before making investing decisions based on enterprise value of the company

Hebei Changshan Investor Information

About 48.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.92. Hebei Changshan Biochem last dividend was issued on the 27th of June 2023. The entity had 18:10 split on the 20th of April 2016. Based on the analysis of Hebei Changshan's profitability, liquidity, and operating efficiency, Hebei Changshan Biochem is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Hebei Changshan Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hebei Changshan has an asset utilization ratio of 30.69 percent. This suggests that the Company is making USD0.31 for each dollar of assets. An increasing asset utilization means that Hebei Changshan Biochem is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Hebei Changshan Ownership Allocation

Hebei Changshan Biochem has a total of 919.06 Million outstanding shares. Hebei Changshan secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Hebei Changshan Profitability Analysis

The company reported the revenue of 1.41 B. Net Loss for the year was (1.24 B) with profit before overhead, payroll, taxes, and interest of 1.02 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hebei Changshan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hebei Changshan and how it compares across the competition.

About Hebei Changshan Valuation

The stock valuation mechanism determines Hebei Changshan's current worth on a weekly basis. Our valuation model uses a comparative analysis of Hebei Changshan. We calculate exposure to Hebei Changshan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hebei Changshan's related companies.
Last ReportedProjected for Next Year
Gross Profit317.4 M301.5 M

Hebei Changshan Quarterly Retained Earnings

291.64 Million

Complementary Tools for Hebei Stock analysis

When running Hebei Changshan's price analysis, check to measure Hebei Changshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hebei Changshan is operating at the current time. Most of Hebei Changshan's value examination focuses on studying past and present price action to predict the probability of Hebei Changshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hebei Changshan's price. Additionally, you may evaluate how the addition of Hebei Changshan to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device